A Multicenter Phase Ib Trial of the Histone Deacetylase Inhibitor Entinostat in Combination with Pembrolizumab in Patients with Myelodysplastic Syndromes/neoplasms or Acute Myeloid Leukemia Refractory to Hypomethylating Agents.
ANNALS OF HEMATOLOGY（2024）
Key words
AML,MDS,Pembrolizumab,Entinostat,Myeloid-derived suppressor cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined